Literature DB >> 21409378

Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study.

Aasma Shaukat1, Daniel J Virnig, Nadim I Salfiti, David H Howard, Shanthi V Sitaraman, Jonathan M Liff.   

Abstract

BACKGROUND: While ulcerative colitis (UC) and Crohn's disease (CD) are thought to predispose to colorectal cancer (CRC), the association has not been well studied in an older population. AIMS: The objective of our study was to evaluate the association of ulcerative colitis and Crohn's disease and colorectal cancer in a population-based, case-control study. We also wished to estimate the incidence rates of colorectal cancer among older individuals with UC/CD.
METHODS: All cases of colorectal cancer in persons 67 and older in the SEER catchment area and in the Medicare claims database were compared with cancer-free controls residing in the same geographic area. We used multivariable logistic regression models adjusted for demographic and other factors.
RESULTS: We identified 47,543 cases of CRC and 142,273 controls. We found a modest association between UC and CRC (OR 1.93; 95% CI 1.54-2.49; P-value<0.001) and a significant, albeit modest, association between CD and CRC (OR 1.45; 95% CI 1.08-1.91; P-value 0.01). We found the incidence of CRC to be 8.2 per 10,000 person-years (95% CI 6.5-10.1/10,000 person-years) among those with UC/CD, and 6.1 per 10,000 person-years (95% CI 4.6-7.8/10,000 person-years) among those without UC/CD, resulting in an incidence rate ratio of 1.34.
CONCLUSIONS: Among older persons ulcerative colitis and Crohn's disease are modest risk factors for CRC, and the incidence rate ratio for CRC is modest, suggesting that risk of CRC in patients with IBD may be lower than previously thought.

Entities:  

Mesh:

Year:  2011        PMID: 21409378     DOI: 10.1007/s10620-011-1632-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Eighteen-year surveillance of dysplasia-associated lesion in ulcerative colitis.

Authors:  J O Lindberg; R B Stenling; J N Rutegard
Journal:  Endoscopy       Date:  2000-04       Impact factor: 10.093

2.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

Review 3.  The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia.

Authors:  S Cotton; L Sharp; J Little
Journal:  Crit Rev Oncog       Date:  1996

4.  Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis.

Authors:  U A Heuschen; U Hinz; E H Allemeyer; J Stern; M Lucas; F Autschbach; C Herfarth; G Heuschen
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

5.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

6.  Family history as a risk factor for colorectal cancer in inflammatory bowel disease.

Authors:  J Askling; P W Dickman; P Karlén; O Broström; A Lapidus; R Löfberg; A Ekbom
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

7.  The relation of age, race, and gender to the subsite location of colorectal carcinoma.

Authors:  R L Nelson; T Dollear; S Freels; V Persky
Journal:  Cancer       Date:  1997-07-15       Impact factor: 6.860

8.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

9.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

10.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

View more
  12 in total

Review 1.  Management of Ulcerative Colitis in the Elderly.

Authors:  Manish P Shrestha; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

2.  Survival in elderly patients with ulcerative colitis and colorectal cancer.

Authors:  Wojciech Blonski; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

Review 3.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 4.  Clinical outcomes and management of inflammatory bowel disease in the older patient.

Authors:  Christina Y Ha; Seymour Katz
Journal:  Curr Gastroenterol Rep       Date:  2013-02

5.  Is ulcerative colitis associated with survival among older persons with colorectal cancer in the US? A population-based case-control study.

Authors:  Aasma Shaukat; Nadim I Salfiti; Daniel J Virnig; David H Howard; Shanthi V Sitaraman; Jonathan M Liff; Frank A Lederle
Journal:  Dig Dis Sci       Date:  2011-11-19       Impact factor: 3.199

6.  Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies.

Authors:  Qianyi Wan; Rui Zhao; Lin Xia; Yutao Wu; Yong Zhou; Yong Wang; Yaping Cui; Xiaoding Shen; Xiao-Ting Wu
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-12       Impact factor: 4.553

Review 7.  Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.

Authors:  Alexis L Franks; Jill E Slansky
Journal:  Anticancer Res       Date:  2012-04       Impact factor: 2.480

Review 8.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

9.  The Vitamin D Receptor, Inflammatory Bowel Diseases, and Colon Cancer.

Authors:  Rong Lu; Shaoping Wu; Yinglin Xia; Jun Sun
Journal:  Curr Colorectal Cancer Rep       Date:  2012-03-01

10.  Clinical trial design for testing the stem cell model for the prevention and treatment of cancer.

Authors:  Rishindra M Reddy; Madhuri Kakarala; Max S Wicha
Journal:  Cancers (Basel)       Date:  2011-06-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.